Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...

Globus Medical’s board of directors authorized a share repurchase program of up to $500 million of the company’s outstanding common stock. Timing and number of repurchased shares will be determined by ...

general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure of Globus Medical ...

general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosure of Globus Medical ...

Globus Medical (NYSE:GMED – Free Report ... and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion ...

While management's discussion of business conditions on theearnings callwill ... or 5 (Strong Sell). For Globus Medical, the Most Accurate Estimate is higher than the Zacks Consensus Estimate ...

Joining today's call from Globus Medical will be Dan Scavilla ... and modular implants paired with versatile instruments to address both degenerative conditions and complex deformities effortlessly ...